カテゴリー： 世界, 医療/バイオ, Grand View Research

世界の網膜静脈閉塞症治療市場（2023-2030）：エンドユーザー別（小売薬局、病院・診療所）、疾患種類別（CRVO、BRVO）、治療薬別（抗VEGF薬、副腎皮質ステロイド薬）、地域別

【英語タイトル】Retinal Vein Occlusion Treatment Market Size, Share & Trends Analysis Report By End-user (Retail Pharmacy, Hospital & Clinics), By Disease Type (CRVO, BRVO), By Treatment (Anti-VEGF, Corticosteroid Drugs), By Region, And Segment Forecasts, 2023 - 2030

Grand View Researchが出版した調査資料（GRV23NOV283）・商品コード：GRV23NOV283
・発行会社（調査会社）：Grand View Research
・発行日：2023年9月
・ページ数：180
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品
◆販売価格オプション（消費税別）
Single UserUSD5,950 ⇒換算￥904,400見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算￥1,056,400見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算￥1,360,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

網膜静脈閉塞症治療市場の成長と動向
Grand View Research, Inc.の最新レポートによると、世界の網膜静脈閉塞症治療市場規模は2030年までに41億8000万米ドルに達し、2023年から2030年までのCAGRは6.92%で成長すると予測されています。眼疾患の有病率の増加、老年人口の増加、眼疾患治療に対する意識の高まりが市場成長を後押しする主な要因です。既存製品や承認済み製品の存在、強力な製品パイプラインは、市場成長を促進すると予想される要因です。さらに、糖尿病とアテローム性動脈硬化症の有病率の増加は、RVOの有病率を高め、調査期間中の市場にプラスの影響を与える可能性があります。RVOに対する新薬の承認の増加は、調査期間中、市場に有利な機会を提供すると予想されます。

サムスンバイオエピスは、黄斑浮腫、新生血管性加齢黄斑変性、近視性脈絡膜新生血管、RVOなどの網膜疾患の治療薬として、初のバイオシミラー医薬品ビョービズ（ラニビズマブ・ヌナ）を開発しました。2020年9月、FDAから商業化の承認を取得しました。しかし、薬剤に関連する高額な費用が薬剤の処方を制限し、市場成長の妨げになる可能性があります。BMC Ophthalmology誌に掲載された2021年の研究によると、ラニビズマブによる中心性RVO（CRVO）および分枝性RVO（BRVO）の治療には、中国では質調整生存年（QALY）当たり約449.17米ドルおよび454.75米ドルの費用がかかります。そのため、高い有効性と安全性を備えた手ごろな価格の医薬品が登場することで、予測される期間中に市場に新たな成長機会がもたらされることが期待されます。

さらに、糖尿病性網膜症、白内障、緑内障、加齢黄斑変性などの疾患が、世界的にこの疾患の主な原因となっています。高齢者人口の増加により、RVOに罹患する人の数も比例して増加しています。加えて、ライフスタイルの変化により、心血管疾患や高血圧など、RVOの原因となる様々な疾患の発生率も増加しています。ランセット・グローバル・ヘルス委員会（Lancet Global Health Commission）の世界の目の健康に関する報告書によると、2020年には世界で5億1,000万人が矯正されていない近見視力障害を、5億9,600万人が矯正されていない遠見視力障害を持つと推定されています。このように、二次的な疾患の有病率の増加はRVOの有病率を高め、市場の成長を支える可能性があります。

網膜静脈閉塞症治療市場レポートハイライト

- 疾患タイプ別では、効率的な治療のための研究開発活動や新規薬剤開発への投資が増加していることから、2022年には分岐セグメントが市場を席巻しました。

- 治療薬別では、抗血管内皮増殖因子（抗VEGF）分野が、その安全性と第一選択薬としての普遍的な受容性により、2022年に最大シェアを獲得しました。

- 小売薬局によるRVO治療薬の入手しやすさの向上や利用可能な選択肢などの要因により、小売薬局のエンドユーザーセグメントが2022年に最大シェアを獲得しました。

- 北米は2022年に41.2%のシェアを獲得し、地域別で確固たる地位を確立しました。これは、同地域の政府助成金の増加による広範な研究開発活動と、治療法の高い採用率の結果です。

第1章. 調査方法・範囲
第2章. エグゼクティブサマリー
第3章. 市場変動・動向・範囲
第4章. 世界の網膜静脈閉塞症治療市場：疾患タイプ別予測・動向分析
第5章. 世界の網膜静脈閉塞症治療市場：治療別予測・動向分析
第6章. 世界の網膜静脈閉塞症治療市場：エンドユーザー別予測・動向分析
第7章. 世界の網膜静脈閉塞症治療市場：地域別予測・動向分析
第8章. 競争状況

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation
1.1.1. Market Definitions
1.2. Objectives
1.2.1. Objective – 1
1.2.2. Objective – 2
1.2.3. Objective – 3
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Gvr’s Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Information Or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.8. List of Secondary Sources
1.9. List of Abbreviations
1.10. List of Primary Sources
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Disease Type and Treatment Snapshot
2.3. End-user Snapshot
2.4. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Segmentation and Scope
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Dynamics
3.4. Market Drivers
3.4.1. Increasing prevalence of retinal diseases
3.4.2. Rising geriatric population
3.4.3. Presence of strong product portfolio
3.5. Market Restraint Analysis
3.5.1. Lack of awareness and underdiagnoses of the disease
3.5.2. High cost of the treatment
3.6. Business Environment Analysis
3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
3.6.2. Porter’s Five Forces Analysis
3.6.3. COVID-19 Impact Analysis
Chapter 4. Disease Type Business Analysis
4.1. Retinal Vein Occlusion Treatment market: Disease Type Movement Analysis
4.2. Central Retinal Vein Occlusion (CRVO)
4.2.1. Central Retinal Vein Occlusion (CRVO) Market, 2018 – 2030 (USD Million)
4.3. Branch Retinal Vein Occlusion (BRVO)
4.3.1. Branch Retinal Vein Occlusion (BRVO) Market, 2018 – 2030 (USD Million)
Chapter 5. Treatment Business Analysis
5.1. Retinal Vein Occlusion Treatment Market: Treatment Movement Analysis
5.2. Anti-vascular Endothelial Growth Factor (Anti-VEGF)
5.2.1. Anti-vascular Endothelial Growth Factor (Anti-VEGF) Market, 2018 – 2030 (USD Million)
5.3. Corticosteroid Drugs
5.3.1. Corticosteroid Drugs Market, 2018 – 2030 (USD Million)
5.4. Others
5.4.1. Others Market, 2018 – 2030 (USD Million)
Chapter 6. End-user Business Analysis
6.1. Retinal Vein Occlusion Treatment Market: End-user Movement Analysis
6.2. Hospital & Clinics
6.2.1. Hospital & Clinics Market, 2018 – 2030 (USD Million)
6.3. Retail Pharmacy
6.3.1. Retail Pharmacy Market, 2018 – 2030 (USD Million)
6.4. Others
6.4.1. Others Market, 2018 – 2030 (USD Million)
Chapter 7. Regional Business Analysis
7.1. Retinal Vein Occlusion Treatment Market Share By Region, 2022 & 2030
7.2. North America
7.2.1. North America Retinal Vein Occlusion Treatment market, 2018 – 2030 (USD Million)
7.2.2. U.S.
7.2.2.1. Key Country Dynamics
7.2.2.2. Target Disease Prevalence
7.2.2.3. Competitive Scenario
7.2.2.4. Regulatory Framework
7.2.2.5. Reimbursement Scenario
7.2.2.6. U.S. Retinal Vein Occlusion Treatment market, 2018 – 2030 (USD MILLION)
7.2.3. Canada
7.2.3.1. Key Country Dynamics
7.2.3.2. Target Disease Prevalence
7.2.3.3. Competitive Scenario
7.2.3.4. Regulatory Framework
7.2.3.5. Reimbursement Scenario
7.2.3.6. Canada Retinal Vein Occlusion Treatment market, 2018 – 2030 (USD Million)
7.3. Europe
7.3.1. Europe Retinal Vein Occlusion Treatment market, 2018 – 2030 (USD Million)
7.3.2. Germany
7.3.2.1. Key Country Dynamics
7.3.2.2. Target Disease Prevalence
7.3.2.3. Competitive Scenario
7.3.2.4. Regulatory Framework
7.3.2.5. Reimbursement Scenario
7.3.2.6. Germany Retinal Vein Occlusion Treatment market, 2018 – 2030 (USD Million)
7.3.3. UK
7.3.3.1. Key Country Dynamics
7.3.3.2. Target Disease Prevalence
7.3.3.3. Competitive Scenario
7.3.3.4. Regulatory Framework
7.3.3.5. Reimbursement Scenario
7.3.3.6. UK Retinal Vein Occlusion Treatment market, 2018 – 2030 (USD Million)
7.3.4. France
7.3.4.1. Key Country Dynamics
7.3.4.2. Target Disease Prevalence
7.3.4.3. Competitive Scenario
7.3.4.4. Regulatory Framework
7.3.4.5. Reimbursement Scenario
7.3.4.6. France Retinal Vein Occlusion Treatment market, 2018 – 2030 (USD Million)
7.3.5. Italy
7.3.5.1. Key Country Dynamics
7.3.5.2. Target Disease Prevalence
7.3.5.3. Competitive Scenario
7.3.5.4. Regulatory Framework
7.3.5.5. Reimbursement Scenario
7.3.5.6. Italy Retinal Vein Occlusion Treatment market, 2018 – 2030 (USD Million)
7.3.6. Spain
7.3.6.1. Key Country Dynamics
7.3.6.2. Target Disease Prevalence
7.3.6.3. Competitive Scenario
7.3.6.4. Regulatory Framework
7.3.6.5. Reimbursement Scenario
7.3.6.6. Spain Retinal Vein Occlusion Treatment market, 2018 – 2030 (USD Million)
7.3.7. Denmark
7.3.7.1. Key Country Dynamics
7.3.7.2. Target Disease Prevalence
7.3.7.3. Competitive Scenario
7.3.7.4. Regulatory Framework
7.3.7.5. Reimbursement Scenario
7.3.7.6. Denmark Retinal Vein Occlusion Treatment market, 2018 – 2030 (USD Million)
7.3.8. Sweden
7.3.8.1. Key Country Dynamics
7.3.8.2. Target Disease Prevalence
7.3.8.3. Competitive Scenario
7.3.8.4. Regulatory Framework
7.3.8.5. Reimbursement Scenario
7.3.8.6. Sweden Retinal Vein Occlusion Treatment market, 2018 – 2030 (USD Million)
7.3.9. Norway
7.3.9.1. Key Country Dynamics
7.3.9.2. Target Disease Prevalence
7.3.9.3. Competitive Scenario
7.3.9.4. Regulatory Framework
7.3.9.5. Reimbursement Scenario
7.3.9.6. Norway Retinal Vein Occlusion Treatment market, 2018 – 2030 (USD Million)
7.4. Asia Pacific
7.4.1. Asia Pacific Retinal Vein Occlusion Treatment market, 2018 – 2030 (USD Million)
7.4.2. Japan
7.4.2.1. Key Country Dynamics
7.4.2.2. Target Disease Prevalence
7.4.2.3. Competitive Scenario
7.4.2.4. Regulatory Framework
7.4.2.5. Reimbursement Scenario
7.4.2.6. Japan Retinal Vein Occlusion Treatment market, 2018 – 2030 (USD Million)
7.4.3. China
7.4.3.1. Key Country Dynamics
7.4.3.2. Target Disease Prevalence
7.4.3.3. Competitive Scenario
7.4.3.4. Regulatory Framework
7.4.3.5. Reimbursement Scenario
7.4.3.6. China Retinal Vein Occlusion Treatment market, 2018 – 2030 (USD Million)
7.4.4. India
7.4.4.1. Key Country Dynamics
7.4.4.2. Target Disease Prevalence
7.4.4.3. Competitive Scenario
7.4.4.4. Regulatory Framework
7.4.4.5. Reimbursement Scenario
7.4.4.6. India Retinal Vein Occlusion Treatment market, 2018 – 2030 (USD Million)
7.4.5. South Korea
7.4.5.1. Key Country Dynamics
7.4.5.2. Target Disease Prevalence
7.4.5.3. Competitive Scenario
7.4.5.4. Regulatory Framework
7.4.5.5. Reimbursement Scenario
7.4.5.6. South Korea Retinal Vein Occlusion Treatment market, 2018 – 2030 (USD Million)
7.4.6. Australia
7.4.6.1. Key Country Dynamics
7.4.6.2. Target Disease Prevalence
7.4.6.3. Competitive Scenario
7.4.6.4. Regulatory Framework
7.4.6.5. Reimbursement Scenario
7.4.6.6. Australia Retinal Vein Occlusion Treatment market, 2018 – 2030 (USD Million)
7.4.7. Thailand
7.4.7.1. Key Country Dynamics
7.4.7.2. Target Disease Prevalence
7.4.7.3. Competitive Scenario
7.4.7.4. Regulatory Framework
7.4.7.5. Reimbursement Scenario
7.4.7.6. Thailand Retinal Vein Occlusion Treatment market, 2018 – 2030 (USD Million)
7.5. Latin America
7.5.1. Latin America Retinal Vein Occlusion Treatment market, 2018 – 2030 (USD Million)
7.5.2. Brazil
7.5.2.1. Key Country Dynamics
7.5.2.2. Target Disease Prevalence
7.5.2.3. Competitive Scenario
7.5.2.4. Regulatory Framework
7.5.2.5. Reimbursement Scenario
7.5.2.6. Brazil Retinal Vein Occlusion Treatment market, 2018 – 2030 (USD Million)
7.5.3. Mexico
7.5.3.1. Key Country Dynamics
7.5.3.2. Target Disease Prevalence
7.5.3.3. Competitive Scenario
7.5.3.4. Regulatory Framework
7.5.3.5. Reimbursement Scenario
7.5.3.6. Mexico Retinal Vein Occlusion Treatment market, 2018 – 2030 (USD Million)
7.5.4. Argentina
7.5.4.1. Key Country Dynamics
7.5.4.2. Target Disease Prevalence
7.5.4.3. Competitive Scenario
7.5.4.4. Regulatory Framework
7.5.4.5. Reimbursement Scenario
7.5.4.6. Argentina Retinal Vein Occlusion Treatment market, 2018 – 2030 (USD Million)
7.6. MEA
7.6.1. MEA Retinal Vein Occlusion Treatment market, 2018 – 2030 (USD Million)
7.6.2. South Africa
7.6.2.1. Key Country Dynamics
7.6.2.2. Target Disease Prevalence
7.6.2.3. Competitive Scenario
7.6.2.4. Regulatory Framework
7.6.2.5. Reimbursement Scenario
7.6.2.6. South Africa Retinal Vein Occlusion Treatment market, 2018 – 2030 (USD Million)
7.6.3. Saudi Arabia
7.6.3.1. Key Country Dynamics
7.6.3.2. Target Disease Prevalence
7.6.3.3. Competitive Scenario
7.6.3.4. Regulatory Framework
7.6.3.5. Reimbursement Scenario
7.6.3.6. Saudi Arabia Retinal Vein Occlusion Treatment market, 2018 – 2030 (USD Million)
7.6.4. UAE
7.6.4.1. Key Country Dynamics
7.6.4.2. Target Disease Prevalence
7.6.4.3. Competitive Scenario
7.6.4.4. Regulatory Framework
7.6.4.5. Reimbursement Scenario
7.6.4.6. UAE Retinal Vein Occlusion Treatment market, 2018 – 2030 (USD Million)
7.6.5. Kuwait
7.6.5.1. Key Country Dynamics
7.6.5.2. Target Disease Prevalence
7.6.5.3. Competitive Scenario
7.6.5.4. Regulatory Framework
7.6.5.5. Reimbursement Scenario
7.6.5.6. Kuwait Retinal Vein Occlusion Treatment market, 2018 – 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Participant’s overview
8.2. Financial performance
8.3. Participant categorization
8.3.1. Market Leaders
8.3.2. Retinal Vein Occlusion Treatment market Share Analysis, 2022
8.3.3. Company Profiles
8.3.3.1. AbbVie Inc
8.3.3.1.1. Company Overview
8.3.3.1.2. Financial Performance
8.3.3.1.3. Product Benchmarking
8.3.3.1.4. Strategic Initiatives
8.3.3.2. F. Hoffmann-La Roche Ltd
8.3.3.2.1. Company Overview
8.3.3.2.2. Financial Performance
8.3.3.2.3. Product Benchmarking
8.3.3.2.4. Strategic Initiatives
8.3.3.3. Regeneron Pharmaceuticals Inc
8.3.3.3.1. Company Overview
8.3.3.3.2. Financial Performance
8.3.3.3.3. Product Benchmarking
8.3.3.3.4. Strategic Initiatives
8.3.3.4. Taiwan Liposome Company, Ltd
8.3.3.4.1. Company Overview
8.3.3.4.2. Financial Performance
8.3.3.4.3. Product Benchmarking
8.3.3.4.4. Strategic Initiatives
8.3.3.5. Aerie Pharmaceuticals Inc
8.3.3.5.1. Company Overview
8.3.3.5.2. Financial Performance
8.3.3.5.3. Product Benchmarking
8.3.3.5.4. Strategic Initiatives
8.3.3.6. CalciMedica Inc
8.3.3.6.1. Company Overview
8.3.3.6.2. Financial Performance
8.3.3.6.3. Product Benchmarking
8.3.3.6.4. Strategic Initiatives
8.3.3.7. Outlook Therapeutics, Inc
8.3.3.7.1. Company Overview
8.3.3.7.2. Financial Performance
8.3.3.7.3. Product Benchmarking
8.3.3.7.4. Strategic Initiatives
8.3.3.8. Kodiak Sciences Inc
8.3.3.8.1. Company Overview
8.3.3.8.2. Financial Performance
8.3.3.8.3. Product Benchmarking
8.3.3.8.4. Strategic Initiatives
8.3.3.9. Chugai Pharmaceutical Co., Ltd
8.3.3.9.1. Company Overview
8.3.3.9.2. Financial Performance
8.3.3.9.3. Product Benchmarking
8.3.3.9.4. Strategic Initiatives
8.3.3.10. Pfizer Inc
8.3.3.10.1. Company Overview
8.3.3.10.2. Financial Performance
8.3.3.10.3. Product Benchmarking
8.3.3.10.4. Strategic Initiatives
8.3.4. Strategy Mapping
8.3.4.1. Expansion
8.3.4.2. Acquisition
8.3.4.3. Collaborations
8.3.4.4. Disease Type/Drug Class Launch
8.3.4.5. Partnerships
8.3.4.6. Others

List of Tables

Table 1 List of Abbreviations
Table 2 Global Retinal Vein Occlusion Treatment Market, by Disease Type, 2018 - 2030 (USD Million)
Table 3 Global Retinal Vein Occlusion Treatment Market, by Treatment, 2018 - 2030 (USD Million)
Table 4 Global Retinal Vein Occlusion Treatment Market, by End-user, 2018 - 2030 (USD Million)
Table 5 Global Retinal Vein Occlusion Treatment Market, by Region, 2018 - 2030 (USD Million)
Table 6 North America Retinal Vein Occlusion Treatment Market, by Country, 2018 - 2030 (USD Million)
Table 7 North America Retinal Vein Occlusion Treatment Market, by Disease Type, 2018 - 2030 (USD Million)
Table 8 North America Retinal Vein Occlusion Treatment Market, by Treatment, 2018 - 2030 (USD Million)
Table 9 North America Retinal Vein Occlusion Treatment Market, by End-user, 2018 - 2030 (USD Million)
Table 10 U.S. Retinal Vein Occlusion Treatment Market, by Disease Type, 2018 - 2030 (USD Million)
Table 11 U.S. Retinal Vein Occlusion Treatment Market, by Treatment, 2018 - 2030 (USD Million)
Table 12 U.S. Retinal Vein Occlusion Treatment Market, by End-user, 2018 - 2030 (USD Million)
Table 13 Canada Retinal Vein Occlusion Treatment Market, by Disease Type, 2018 - 2030 (USD Million)
Table 14 Canada Retinal Vein Occlusion Treatment Market, by Treatment, 2018 - 2030 (USD Million)
Table 15 Canada Retinal Vein Occlusion Treatment Market, by End-user, 2018 - 2030 (USD Million)
Table 16 Europe Retinal Vein Occlusion Treatment Market, by Country, 2018 - 2030 (USD Million)
Table 17 Europe Retinal Vein Occlusion Treatment Market, by Disease Type, 2018 - 2030 (USD Million)
Table 18 Europe Retinal Vein Occlusion Treatment Market, by Treatment, 2018 - 2030 (USD Million)
Table 19 Europe Retinal Vein Occlusion Treatment Market, by End-user, 2018 - 2030 (USD Million)
Table 20 Germany Retinal Vein Occlusion Treatment Market, by Disease Type, 2018 - 2030 (USD Million)
Table 21 Germany Retinal Vein Occlusion Treatment Market, by Treatment, 2018 - 2030 (USD Million)
Table 22 Germany Retinal Vein Occlusion Treatment Market, by End-user, 2018 - 2030 (USD Million)
Table 23 UK Retinal Vein Occlusion Treatment Market, by Disease Type, 2018 - 2030 (USD Million)
Table 24 UK Retinal Vein Occlusion Treatment Market, by Treatment, 2018 - 2030 (USD Million)
Table 25 UK Retinal Vein Occlusion Treatment Market, by End-user, 2018 - 2030 (USD Million)
Table 26 France Retinal Vein Occlusion Treatment Market, by Disease Type, 2018 - 2030 (USD Million)
Table 27 France Retinal Vein Occlusion Treatment Market, by Treatment, 2018 - 2030 (USD Million)
Table 28 France Retinal Vein Occlusion Treatment Market, by End-user, 2018 - 2030 (USD Million)
Table 29 Italy Retinal Vein Occlusion Treatment Market, by Disease Type, 2018 - 2030 (USD Million)
Table 30 Italy Retinal Vein Occlusion Treatment Market, by Treatment, 2018 - 2030 (USD Million)
Table 31 Italy Retinal Vein Occlusion Treatment Market, by End-user, 2018 - 2030 (USD Million)
Table 32 Spain Retinal Vein Occlusion Treatment Market, by Disease Type, 2018 - 2030 (USD Million)
Table 33 Spain Retinal Vein Occlusion Treatment Market, by Treatment, 2018 - 2030 (USD Million)
Table 34 Spain Retinal Vein Occlusion Treatment Market, by End-user, 2018 - 2030 (USD Million)
Table 35 Denmark Retinal Vein Occlusion Treatment Market, by Disease Type, 2018 - 2030 (USD Million)
Table 36 Denmark Retinal Vein Occlusion Treatment Market, by Treatment, 2018 - 2030 (USD Million)
Table 37 Denmark Retinal Vein Occlusion Treatment Market, by End-user, 2018 - 2030 (USD Million)
Table 38 Sweden Retinal Vein Occlusion Treatment Market, by Disease Type, 2018 - 2030 (USD Million)
Table 39 Sweden Retinal Vein Occlusion Treatment Market, by Treatment, 2018 - 2030 (USD Million)
Table 40 Sweden Retinal Vein Occlusion Treatment Market, by End-user, 2018 - 2030 (USD Million)
Table 41 Norway Retinal Vein Occlusion Treatment Market, by Disease Type, 2018 - 2030 (USD Million)
Table 42 Norway Retinal Vein Occlusion Treatment Market, by Treatment, 2018 - 2030 (USD Million)
Table 43 Norway Retinal Vein Occlusion Treatment Market, by End-user, 2018 - 2030 (USD Million)
Table 44 Asia Pacific Retinal Vein Occlusion Treatment Market, by Country, 2018 - 2030 (USD Million)
Table 45 Asia Pacific Retinal Vein Occlusion Treatment Market, by Disease Type, 2018 - 2030 (USD Million)
Table 46 Asia Pacific Retinal Vein Occlusion Treatment Market, by Treatment, 2018 - 2030 (USD Million)
Table 47 Asia Pacific Retinal Vein Occlusion Treatment Market, by End-user, 2018 - 2030 (USD Million)
Table 48 China Retinal Vein Occlusion Treatment Market, by Disease Type, 2018 - 2030 (USD Million)
Table 49 China Retinal Vein Occlusion Treatment Market, by Treatment, 2018 - 2030 (USD Million)
Table 50 China Retinal Vein Occlusion Treatment Market, by End-user, 2018 - 2030 (USD Million)
Table 51 Japan Retinal Vein Occlusion Treatment Market, by Disease Type, 2018 - 2030 (USD Million)
Table 52 Japan Retinal Vein Occlusion Treatment Market, by Treatment, 2018 - 2030 (USD Million)
Table 53 Japan Retinal Vein Occlusion Treatment Market, by End-user, 2018 - 2030 (USD Million)
Table 54 India Retinal Vein Occlusion Treatment Market, by Disease Type, 2018 - 2030 (USD Million)
Table 55 India Retinal Vein Occlusion Treatment Market, by Treatment, 2018 - 2030 (USD Million)
Table 56 India Retinal Vein Occlusion Treatment Market, by End-user, 2018 - 2030 (USD Million)
Table 57 South Korea Retinal Vein Occlusion Treatment Market, by Disease Type, 2018 - 2030 (USD Million)
Table 58 South Korea Retinal Vein Occlusion Treatment Market, by Treatment, 2018 - 2030 (USD Million)
Table 59 South Korea Retinal Vein Occlusion Treatment Market, by End-user, 2018 - 2030 (USD Million)
Table 60 Australia Retinal Vein Occlusion Treatment Market, by Disease Type, 2018 - 2030 (USD Million)
Table 61 Australia Retinal Vein Occlusion Treatment Market, by Treatment, 2018 - 2030 (USD Million)
Table 62 Australia Retinal Vein Occlusion Treatment Market, by End-user, 2018 - 2030 (USD Million)
Table 63 Thailand Retinal Vein Occlusion Treatment Market, by Disease Type, 2018 - 2030 (USD Million)
Table 64 Thailand Retinal Vein Occlusion Treatment Market, by Treatment, 2018 - 2030 (USD Million)
Table 65 Thailand Retinal Vein Occlusion Treatment Market, by End-user, 2018 - 2030 (USD Million)
Table 66 Latin America Retinal Vein Occlusion Treatment Market, by Country, 2018 - 2030 (USD Million)
Table 67 Latin America Retinal Vein Occlusion Treatment Market, by Disease Type, 2018 - 2030 (USD Million)
Table 68 Latin America Retinal Vein Occlusion Treatment Market, by Treatment, 2018 - 2030 (USD Million)
Table 69 Latin America Retinal Vein Occlusion Treatment Market, by End-user, 2018 - 2030 (USD Million)
Table 70 Brazil Retinal Vein Occlusion Treatment Market, by Disease Type, 2018 - 2030 (USD Million)
Table 71 Brazil Retinal Vein Occlusion Treatment Market, by Treatment, 2018 - 2030 (USD Million)
Table 72 Brazil Retinal Vein Occlusion Treatment Market, by End-user, 2018 - 2030 (USD Million)
Table 73 Mexico Retinal Vein Occlusion Treatment Market, by Disease Type, 2018 - 2030 (USD Million)
Table 74 Mexico Retinal Vein Occlusion Treatment Market, by Treatment, 2018 - 2030 (USD Million)
Table 75 Mexico Retinal Vein Occlusion Treatment Market, by End-user, 2018 - 2030 (USD Million)
Table 76 Argentina Retinal Vein Occlusion Treatment Market, by Disease Type, 2018 - 2030 (USD Million)
Table 77 Argentina Retinal Vein Occlusion Treatment Market, by Treatment, 2018 - 2030 (USD Million)
Table 78 Argentina Retinal Vein Occlusion Treatment Market, by End-user, 2018 - 2030 (USD Million)
Table 79 Middle East & Africa Retinal Vein Occlusion Treatment Market, by Country, 2018 - 2030 (USD Million)
Table 80 Middle East & Africa Retinal Vein Occlusion Treatment Market, by Treatment, 2018 - 2030 (USD Million)
Table 81 Middle East & Africa Retinal Vein Occlusion Treatment Market, by End-user, 2018 - 2030 (USD Million)
Table 82 Middle East & Africa Retinal Vein Occlusion Treatment Market, by Disease Type, 2018 - 2030 (USD Million)
Table 83 South Africa Retinal Vein Occlusion Treatment Market, by Disease Type, 2018 - 2030 (USD Million)
Table 84 South Africa Retinal Vein Occlusion Treatment Market, by Treatment, 2018 - 2030 (USD Million)
Table 85 South Africa Retinal Vein Occlusion Treatment Market, by End-user, 2018 - 2030 (USD Million)
Table 86 Saudi Arabia Retinal Vein Occlusion Treatment Market, by Disease Type, 2018 - 2030 (USD Million)
Table 87 Saudi Arabia Retinal Vein Occlusion Treatment Market, by Treatment, 2018 - 2030 (USD Million)
Table 88 Saudi Arabia Retinal Vein Occlusion Treatment Market, by End-user, 2018 - 2030 (USD Million)
Table 89 UAE Retinal Vein Occlusion Treatment Market, by Disease Type, 2018 - 2030 (USD Million)
Table 90 UAE Retinal Vein Occlusion Treatment Market, by Treatment, 2018 - 2030 (USD Million)
Table 91 UAE Retinal Vein Occlusion Treatment Market, by End-user, 2018 - 2030 (USD Million)
Table 92 Kuwait Retinal Vein Occlusion Treatment Market, by Disease Type, 2018 - 2030 (USD Million)
Table 93 Kuwait Retinal Vein Occlusion Treatment Market, by Treatment, 2018 - 2030 (USD Million)
Table 94 Kuwait Retinal Vein Occlusion Treatment Market, by End-user, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Information Procurement
Fig. 3 Primary Research Pattern
Fig. 4 Market Research Approaches
Fig. 5 Value Chain-Based Sizing & Forecasting
Fig. 6 Market Formulation & Validation
Fig. 7 Retinal Vein Occlusion Treatment Market Segmentation
Fig. 8 Market Snapshot, 2022
Fig. 9 Market Trends & Outlook
Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 12 PESTEL Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 13 Porter’s Five Forces Analysis
Fig. 14 Global Retinal Vein Occlusion Treatment Market: Disease Type Movement Analysis
Fig. 15 Global Retinal Vein Occlusion Treatment Market, by Central Retinal Vein Occlusion (CRVO), 2018 - 2030 (USD Million)
Fig. 16 Global Retinal Vein Occlusion Treatment Market, by Branch Retinal Vein Occlusion (BRVO), 2018 - 2030 (USD Million)
Fig. 17 Global Retinal Vein Occlusion Treatment Market: Treatment Movement Analysis
Fig. 18 Global Retinal Vein Occlusion Treatment Market, by Anti-vascular Endothelial Growth Factor (Anti-VEGF), 2018 - 2030 (USD Million)
Fig. 19 Global Retinal Vein Occlusion Treatment Market, by Corticosteroid Drugs, 2018 - 2030 (USD Million)
Fig. 20 Global Retinal Vein Occlusion Treatment Market, by Others, 2018 - 2030 (USD Million)
Fig. 21 Global Retinal Vein Occlusion Treatment Market: End-user Movement Analysis
Fig. 22 Global Retinal Vein Occlusion Treatment Market, by Hospital & Clinics 2018 - 2030 (USD Million)
Fig. 23 Global Retinal Vein Occlusion Treatment Market, by Retail Pharmacy 2018 - 2030 (USD Million)
Fig. 24 Global Retinal Vein Occlusion Treatment Market, by Others, 2018 - 2030 (USD Million)
Fig. 25 Regional Marketplace: Key Takeaways
Fig. 26 Regional Outlook, 2022 & 2030
Fig. 27 Global Retinal Vein Occlusion Treatment Market: Region Movement Analysis
Fig. 28 North America Retinal Vein Occlusion Treatment Market, 2018 - 2030 (USD Million)
Fig. 29 U.S. Retinal Vein Occlusion Treatment Market, 2018 - 2030 (USD Million)
Fig. 30 Canada Retinal Vein Occlusion Treatment Market, 2018 - 2030 (USD Million)
Fig. 31 Europe Retinal Vein Occlusion Treatment Market, 2018 - 2030 (USD Million)
Fig. 32 Germany Retinal Vein Occlusion Treatment Market, 2018 - 2030 (USD Million)
Fig. 33 UK Retinal Vein Occlusion Treatment Market, 2018 - 2030 (USD Million)
Fig. 34 France Retinal Vein Occlusion Treatment Market, 2018 - 2030 (USD Million)
Fig. 35 Italy Retinal Vein Occlusion Treatment Market, 2018 - 2030 (USD Million)
Fig. 36 Spain Retinal Vein Occlusion Treatment Market, 2018 - 2030 (USD Million)
Fig. 37 Denmark Retinal Vein Occlusion Treatment Market, 2018 - 2030 (USD Million)
Fig. 38 Sweden Retinal Vein Occlusion Treatment Market, 2018 - 2030 (USD Million)
Fig. 39 Norway Retinal Vein Occlusion Treatment Market, 2018 - 2030 (USD Million)
Fig. 40 Asia Pacific Retinal Vein Occlusion Treatment Market, 2018 - 2030 (USD Million)
Fig. 41 Japan Retinal Vein Occlusion Treatment Market, 2018 - 2030 (USD Million)
Fig. 42 China Retinal Vein Occlusion Treatment Market, 2018 - 2030 (USD Million)
Fig. 43 India Retinal Vein Occlusion Treatment Market, 2018 - 2030 (USD Million)
Fig. 44 Australia Retinal Vein Occlusion Treatment Market, 2018 - 2030 (USD Million)
Fig. 45 South Korea Retinal Vein Occlusion Treatment Market, 2018 - 2030 (USD Million)
Fig. 46 Thailand Retinal Vein Occlusion Treatment Market, 2018 - 2030 (USD Million)
Fig. 47 Latin America Retinal Vein Occlusion Treatment Market, 2018 - 2030 (USD Million)
Fig. 48 Brazil Retinal Vein Occlusion Treatment Market, 2018 - 2030 (USD Million)
Fig. 49 Mexico Retinal Vein Occlusion Treatment Market, 2018 - 2030 (USD Million)
Fig. 50 Argentina Retinal Vein Occlusion Treatment Market, 2018 - 2030 (USD Million)
Fig. 51 Middle East and Africa Retinal Vein Occlusion Treatment Market, 2018 - 2030 (USD Million)
Fig. 52 South Africa Retinal Vein Occlusion Treatment Market, 2018 - 2030 (USD Million)
Fig. 53 Saudi Arabia Retinal Vein Occlusion Treatment Market, 2018 - 2030 (USD Million)
Fig. 54 UAE Retinal Vein Occlusion Treatment Market, 2018 - 2030 (USD Million)
Fig. 55 Kuwait Retinal Vein Occlusion Treatment Market, 2018 - 2030 (USD Million)

★調査レポート[世界の網膜静脈閉塞症治療市場（2023-2030）：エンドユーザー別（小売薬局、病院・診療所）、疾患種類別（CRVO、BRVO）、治療薬別（抗VEGF薬、副腎皮質ステロイド薬）、地域別] (コード：GRV23NOV283)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の網膜静脈閉塞症治療市場（2023-2030）：エンドユーザー別（小売薬局、病院・診療所）、疾患種類別（CRVO、BRVO）、治療薬別（抗VEGF薬、副腎皮質ステロイド薬）、地域別]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の腫瘍コンパニオン診断市場（2023-2030）：製品・サービス別、技術別（IHC、NGS）、疾患種類別（乳がん、白血病）、エンドユーザー別、地域別
  • 世界の緑内障市場2023-2030：疾患種類別（開放隅角緑内障、閉塞隅角緑内障）、薬剤クラス別（プロスタグランジン類縁体、ベータ遮断薬）、流通チャネル別、地域別
  • 世界の抗ウイルス薬市場2023-2030：タイプ別（ブランド、ジェネリック）、薬剤クラス別、流通チャネル別（病院薬局、小売薬局）、用途別、地域別
  • 世界のデュピュイトラン病市場2023-2030：種類別（診断、治療）、疾患種類別（タイプ I、タイプ II）、最終用途別（病院、診療所）、地域別（ヨーロッパ、アジア太平洋）
  • 世界のがん免疫療法市場2024-2030：製品別、用途別、流通別（病院薬局、小売薬局、オンライン薬局）、エンドユーザー別、地域別
  • 世界の婦人科用治療薬市場（2023-2033)：疾患別（婦人科系がん、避妊、女性不妊症、更年期障害、多嚢胞性卵巣症候群（PCOS）、その他）、治療薬別（非ホルモン治療薬、ホルモン治療薬）、流通チャネル別（病院薬局、小売薬局、オンライン薬局）、種類別（ジェネリック、ブランド）、地域別
  • 世界の尿路感染症検査市場（2023-2030）：種類別（尿道炎、膀胱炎、腎盂腎炎）、エンドユーザー別（レファレンスラボラトリー、一般開業医、泌尿器科医）、地域別
  • 世界のインフルエンザ治療薬市場2024-2030：治療薬別（ペラミビル、ザナミビル、バロキサビル マルボキシル、リン酸オセルタミビル）、投与経路別、流通チャネル別、地域別
  • 世界の前立腺がん診断薬市場（2023-2030）：検査種類別（予備検査、確認検査）、種類別（腺がん、間質細胞がん）、エンドユーザー別（病院、外来施設）、地域別

    • ◆H&Iグローバルリサーチのお客様（例）◆